A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size
Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 25, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new real-time system designed to help doctors accurately estimate the size of colorectal polyps during colonoscopy. Understanding the size of these polyps is important because larger polyps (especially those over 10 mm) can indicate a higher risk of advanced features or colorectal cancer. By measuring polyp size correctly, doctors can make better decisions about patient care, including how often patients need surveillance and what type of treatment may be necessary. The trial aims to improve the accuracy of these measurements, which could lead to earlier diagnoses and better outcomes for patients.
To participate in this trial, individuals must be 18 years or older and have undergone a colonoscopy for screening or investigation of symptoms. Those who are not eligible include individuals with certain medical conditions that could make colonoscopy unsafe or those who have serious health issues. If you join the trial, you will help researchers gather important information that could enhance how doctors assess and manage colorectal polyps in the future. The trial is not yet recruiting participants, so there will be more information available soon for those interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Subjects are eligible if:
- • 1. They have received colonoscopy for screening, surveillance or symptom investigation;
- • 2. Aged 18 years older or above;
- • 3. Written informed consent obtained.
- Exclusion Criteria:
- Subjects are excluded if they have:
- • 1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation)
- • 2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets)
- • 3. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Louis HS Lau, FRCP
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported